impact of checkpoint inhibitor-based salvage regimens prior to allosct in r/r chl
Published 1 year ago • 31 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
4:27
the role of immune checkpoint inhibitors in mds
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:53
toxicities and new immune checkpoint inhibitors
-
6:44
checkpoint inhibitor advances in aml
-
1:27
the promise of novel checkpoint inhibitors for the treatment of hl
-
3:21
nox2: a potential immune checkpoint for inhibition in aml
-
6:31
what are checkpoint inhibitors?
-
7:32
current immune checkpoint inhibitor trials in aml/mds
-
5:46
the use of allogeneic transplantation in the era of checkpoint blockade therapy in hodgkin lymphoma
-
2:15
a summary of lymphoma immune checkpoint inhibitor data at eha 2017
-
5:20
immuno-oncology agents for mm: checkpoint inhibitors and nk-cells
-
2:54
pre/post allo-sct checkpoint inhibitors: a double-edged sword
-
2:53
immune checkpoint inhibitors in mds: the i4mds consortium
-
1:11
distinkt trial analysis: efficacy and safety of imc-001 for r/r enktl
-
17:44
immune checkpoint inhibitors in lymphoma
-
12:48
impact of immune checkpoint inhibitors
-
1:40
checkpoint inhibitors in hodgkin lymphoma
-
2:15
cd47-blocking checkpoint inhibitor tti-621 shows promising results for cutaneous t-cell lymphomas